1. Home
  2. NVAX vs ERO Comparison

NVAX vs ERO Comparison

Compare NVAX & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Ero Copper Corp.

ERO

Ero Copper Corp.

HOLD

Current Price

$27.49

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
ERO
Founded
1987
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
ERO
Price
$6.82
$27.49
Analyst Decision
Hold
Strong Buy
Analyst Count
8
2
Target Price
$9.75
$28.50
AVG Volume (30 Days)
3.2M
1.1M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
696.31
EPS
2.07
1.33
Revenue
$1,064,651,000.00
$588,229,000.00
Revenue This Year
$58.91
$67.70
Revenue Next Year
N/A
$45.19
P/E Ratio
$3.29
$20.67
Revenue Growth
20.27
26.74
52 Week Low
$5.01
$9.30
52 Week High
$11.55
$28.60

Technical Indicators

Market Signals
Indicator
NVAX
ERO
Relative Strength Index (RSI) 48.21 68.06
Support Level $6.36 $24.50
Resistance Level $7.00 $28.60
Average True Range (ATR) 0.21 1.08
MACD 0.07 0.14
Stochastic Oscillator 71.88 77.50

Price Performance

Historical Comparison
NVAX
ERO

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: